Date: 2015-10-02
Type of information: Collaboration agreement
Compound: health services
Company: Allergan (Ireland) Humana (USA - KY)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On October 2, 2015, Allergan announced a multi-year research collaboration with Humana, one of the US leading health and well-being companies, to explore new ideas and ways to improve the health and well-being of patients, members and their caregivers. A main objective of the Allergan and Humana collaboration is to study key issues and obtain a more comprehensive understanding of opportunities for improvement in care delivery. Under the terms of the agreement, Allergan and Humana will initially focus on the following initiatives:
Variety of Diseases - Improving health of patients with central nervous system conditions, including Alzheimer's disease, as well as glaucoma and other eye diseases with opportunities to expand into other therapeutic areas as the collaboration progresses.
Patient/Caregiver Relationship - Obtain a clearer picture of the attributes associated with caregiver burden from the caregiver perspective, and how self-reported caregiver burden relates to healthcare-related utilization and costs.
Interventional Research - Conduct research based on interventional practices and predictive analytics, with a focus on treatment adherence, to ensure patients obtain the right medications at the right time.
One of the collaboration's first projects focuses on Alzheimer's patients' caregiver burden. Unlike caregiving for many terminal illnesses, caregiving for Alzheimer's disease may persist for much longer given that patients with Alzheimer's disease can live for many years.
Financial terms:
Latest news:
